Global AI in Mental Health Market | Key Players are Wysa Ltd, Woebot Health, Ginger, Marigold Health, Mindstrong Health, Bark Technologies and many more

The market size of the Global AI in Mental Health Market is predicted to exhibit a 38.14% CAGR during the forecast period.

Curious about this latest version of report? Obtain Report Details@ https://www.insightaceanalytic.com/report/global-ai-in-mental-health-market-/1272

With the emergence of digital methods for mental health, current artificial intelligence (AI) (machine learning in particular) is being utilized to build mental health care solutions for prediction, detection, and therapy. Despite major advancements in digital health and the application of AI to physical health in general, the use of AI in mental health is still in its infancy. However, opportunities are emerging.

The outbreak of the COVID-19 pandemic provided a chance to demonstrate AI’s capabilities and complexity in the healthcare industry. During the pandemic’s second wave, hospitals and clinics around the world used AI-based virtual assistants, inpatient care bots, and AI-assisted surgery robots to deal with the constant influx of patients, which would have otherwise swamped the entire hospital operation cycle. The market is being driven by a growing number of cross-industry partnerships and collaborations, as well as an increasing imbalance between the health workforce and patients, which is driving the need for improved healthcare services. The market is also being driven by the growing demand to reduce rising healthcare costs, improving computing power and declining hardware costs, and a growing number of cross-industry partnerships and collaborations. However, several healthcare practitioners are doubtful of AI’s ability to diagnose patient ailments effectively.

List of Prominent Players in the AI in Mental Health Market:

Wysa Ltd

Woebot Health

Ginger

Marigold Health

Mindstrong Health

Bark Technologies

BioBeats

Cognoa

Lyra Health

MeQuilibrium

For More Information @ https://www.insightaceanalytic.com/report/global-ai-in-mental-health-market-/1272

Market Dynamics:

Drivers-

AI can be incorporated into digital interventions, especially online and smartphone apps, to improve user experience and improve personalized mental health care. Increased prevalence of mental disorders, growing patient base and number of people adopting mental health solutions, and increased focus of medical professionals on providing excellent treatment to patients with mental illness are anticipated to be the primary factors driving market expansion. With the use of AI mental health systems, physicians and physicists may simplify their operations. Moreover, increasing smartphone and internet penetration are driving market expansion. In addition, funding opportunities and strategic collaborations by a wide range of organizations are anticipated to fuel market expansion throughout the projection period.

Challenges:

AI has a number of uses in healthcare. However, due to data privacy issues, the industry’s use of AI is limited. In several countries, patient health data is protected by federal regulations, and any breach or failure to maintain its integrity can result in legal and financial penalties. Because AI for patient care requires access to numerous health datasets, AI-based technologies must follow all data security regulations by governments and regulatory bodies. This is a challenging process because most AI platforms are concentrated and demand a lot of computational capacity, so patient data, or parts of it, may have to be stored in a vendor’s data centre. 

Regional Trends:

North America region is expected to dominate the artificial intelligence in the mental health market over the forecast period. The increasing implementation of AI technology across the continuum of care, particularly in the United States, and high healthcare spending, together with the advent of the COVID-19 pandemic, are the primary reasons driving the growth of the North American market. The increasing size and complexity of datasets driving the need for AI, rising demand to reduce rising healthcare costs, improving computing power and decreasing hardware costs, a growing number of cross-industry partnerships and collaborations, and rising imbalance between health workforce and patients driving the need for improved healthcare services are the major market drivers.

Recent Developments:

• In March 2022, Woebot Health announced that Leaps by Bayer, the impact investing arm of Bayer AG, has made a $9.5 million strategic investment in the firm in order to expedite the development of its AI-powered behavioural health platform and solutions. Woebot Health is opening a new frontier in behavioural health at a crucial global moment by emphasizing clinical evidence and utilizing an AI-based platform and solutions.
• In May 2021, The Series A fundraising round for Wysa, an AI-powered mental health app, was headed by Boston-based digital health investors W Health Ventures. The company will utilize the new capital to extend its solutions for B2B clients and recruit additional personnel to meet anticipated future demand.

Segmentation of AI in Mental Health Market-

By Application

• Conversational Interfaces
• Patient Behavioral Pattern Recognition

By Technology

• Machine Learning and Deep Learning
• Natural Language Processing (NLP)
• Others

By Component

• Software-as-a-Service (SaaS)
• Hardware

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1272

Tags: Global AI in Mental Health Market See Campaign: https://www.insightaceanalytic.com

Contact Information:

+1 551 226 6109 Email: info@insightaceanalytic.com

Tags:
Financial Content, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English